| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:06 | RBC Capital reiterates GE Vernova stock rating on strong orders | ||
| 14:06 | Argus upgrades UnitedHealth stock rating on cost management gains | ||
| 13:54 | BTQ appoints quantum algorithms head, expands Sydney operations | ||
| 13:54 | BullFrog AI regains Nasdaq compliance with equity rule | ||
| 13:54 | FCC grants AST SpaceMobile authority for satellite broadband service | ||
| 13:54 | RenX expects Q1 revenue above $3.5M, up from Q4 2025 | ||
| 13:54 | TuHURA Biosciences secures $50M credit facility from affiliate | ||
| 13:54 | Classover partners with ICreate on AI robotics education | ||
| 13:54 | Valour secures $11M institutional investment in Hedera ETPs | ||
| 13:54 | Webuy reports $3.34 million in bookings at Singapore travel fair | ||
| 13:54 | Boost Run signs $1.44 billion Dell purchase agreement for AI infrastructure | ||
| 13:54 | Faron Pharmaceuticals reports Heights Capital stake at 25.44% | ||
| 13:54 | Northland downgrades Calix stock rating on margin pressure | ||
| 13:54 | Northland highlights AI edge chip stocks amid semiconductor cycle concerns | ||
| 13:54 | H.C. Wainwright reiterates Eupraxia stock rating citing trial data | ||
| 13:54 | H.C. Wainwright reiterates Janux Therapeutics stock rating at buy | ||
| 13:54 | Wainwright reiterates Iovanace Biotherapeutics stock rating at buy | ||
| 13:54 | H.C. Wainwright reiterates Buy on Actuate Therapeutics stock | ||
| 13:54 | H.C. Wainwright reiterates Foghorn Therapeutics stock rating at buy | ||
| 13:30 | Caliber advances three Hyatt Studios hotel developments | ||
| 13:30 | Certara to sell regulatory writing unit to Veristat for $135M | ||
| 13:30 | Rafael unit secures MIT license for Alzheimer's treatment | ||
| 13:30 | ParkerVision appeal arguments set for June 1, trial dates postponed | ||
| 13:30 | H.C. Wainwright reiterates Molecular Partners stock rating at buy | ||
| 13:30 | Surf Air Mobility stock rating reiterated at Buy by H.C. Wainwright |